Positive, stigma-free prostate health education backed by reputable medical sources. Understanding your body is the first step toward protecting it.
The prostate is a walnut-sized gland located just below the bladder and in front of the rectum, surrounding part of the urethra. Its primary function is producing prostatic fluid — a component of semen that nourishes and transports sperm. The NHS provides a complete overview of prostate anatomy and common conditions.
As men age, the prostate naturally tends to enlarge — a condition called benign prostatic hyperplasia (BPH). According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), BPH affects approximately 50% of men aged 51-60 and up to 90% of men over 80. It is not cancer, but it can cause urinary symptoms that affect quality of life.
For men of African and Caribbean heritage, prostate awareness is particularly important. Cancer Research UK data shows that Black men in the UK are approximately twice as likely to be diagnosed with prostate cancer as White men — and are also more likely to be diagnosed at a younger age and with more advanced disease. The Prostate Cancer UK risk page identifies African-Caribbean heritage as one of the three primary risk factors (alongside age and family history).
This isn't cause for fear — it's cause for informed, proactive action. Early detection through screening dramatically improves outcomes. The purpose of this page is to give you the knowledge you need to have confident, informed conversations with your healthcare provider.
PSA (prostate-specific antigen) is a protein produced by both normal and abnormal prostate cells. A PSA blood test measures the concentration of this protein in your blood, reported in nanograms per millilitre (ng/mL). The NHS PSA testing page provides the official UK guidance on who should be tested and what results mean.
There is no single "normal" PSA level — it varies by age, ethnicity, prostate size, and individual factors. As a general reference framework used by many clinicians:
However, what matters most is the trend over time. A rapidly rising PSA (known as PSA velocity) may be more significant than a single elevated reading. This is why establishing a baseline PSA in your 40s is so valuable — it gives your doctor a reference point for future comparisons.
An elevated PSA does not automatically indicate cancer. Many benign factors can temporarily raise PSA:
According to Prostate Cancer UK, approximately 3 in 4 men with an elevated PSA do NOT have prostate cancer. This is why further investigation (MRI, biopsy) is used to determine the cause.
The Prostate Cancer UK recommends that Black men can request a PSA test from their GP from age 45. If you have a first-degree relative (father or brother) who has had prostate concerns, discussing testing from age 40 may be appropriate. In England, men over 50 can request a PSA test through the NHS Prostate Cancer Risk Management Programme.
The Prostate Cancer Foundation (US) recommends baseline PSA testing at age 40-45 for men at higher risk, including Black men and those with family history. Getting tested is a proactive, empowering step — not a sign that anything is wrong.
If a PSA result warrants further investigation, your doctor will typically refer you for a multiparametric MRI (mpMRI) of the prostate. This is now the recommended first-line investigation before biopsy in the UK, following the landmark PROMIS trial published in The Lancet (2017), which demonstrated that MRI-first pathways reduce unnecessary biopsies while improving detection of clinically significant disease.
An MRI uses powerful magnetic fields and radio waves — not ionising radiation — to create detailed cross-sectional images. The NHS MRI scan guide explains the procedure in full.
PI-RADS (Prostate Imaging Reporting and Data System) is the international standardised system for reporting prostate MRI findings, currently in version 2.1. It was developed by the American College of Radiology in collaboration with the European Society of Urogenital Radiology. Each lesion identified on MRI is assigned a score from 1 to 5:
Important context: A PI-RADS 3 or 4 score does not mean you have cancer. It means a specific area of the prostate looks different enough on MRI to warrant closer examination. The MRI serves to guide the next step — making any subsequent biopsy more precise and targeted. You can read the full PI-RADS guidelines at the American College of Radiology PI-RADS page.
Duration: 30-45 minutes. You'll lie on a scanning table that slides into a large cylindrical machine. The machine is noisy (you'll be given headphones or earplugs). You must stay still throughout. Some scans involve an intravenous contrast agent (gadolinium) to enhance image quality. The scan itself is painless. Claustrophobia is the most common concern — inform the team beforehand if this affects you, as some centres offer open MRI machines or sedation.
For a patient-friendly explanation of what happens during a prostate MRI, Prostate Cancer UK's MRI guide is an excellent resource.
A prostate biopsy involves taking small tissue samples (typically 12-24 cores) from the prostate gland for microscopic examination by a pathologist. This is the definitive method for determining whether changes in the prostate are benign or significant.
Historically, most prostate biopsies were performed transrectally (TRUS biopsy) — through the wall of the rectum. While effective, this approach carries a small but significant risk of sepsis (serious infection) due to bacteria entering the bloodstream from the rectum. In the UK, approximately 1-3% of TRUS biopsies resulted in hospital admission for sepsis.
The transperineal approach — accessing the prostate through the perineum (the skin between the scrotum and rectum) — has become the preferred method in many centres. In 2024, NICE (National Institute for Health and Care Excellence) updated its guidance to recommend the transperineal approach as standard. Benefits include:
The Prostate Cancer UK biopsy guide explains both approaches in patient-friendly detail.
If a biopsy is performed, the pathologist assigns a Gleason score based on the microscopic appearance of the tissue. The Gleason system (graded 6-10) has been supplemented by the newer Grade Group system (1-5) for clearer communication:
The National Cancer Institute (NCI) provides a comprehensive guide to understanding pathology results.
Common after-effects include blood in urine (haematuria — usually resolves within 1-2 weeks), blood in semen (may persist for several weeks, which is normal), mild bruising or discomfort in the perineal area, and temporary difficulty urinating. Results typically take 1-3 weeks. The waiting period can be anxious — but you've taken a brave step that gives you and your clinical team the information needed to make the best decisions for your health.
The evidence for racial disparities in prostate health is extensive and well-documented across multiple countries and healthcare systems:
The reasons are multifactorial and include genetic predisposition (certain gene variants are more prevalent in men of West African descent), dietary patterns, access to healthcare, socioeconomic factors, and historical mistrust of medical institutions. Research from the Institute of Cancer Research and Orchid (the male cancer charity) is ongoing.
This information isn't shared to cause alarm — it's shared because knowledge enables action. Men who are aware of their risk profile and engage in proactive screening have significantly better outcomes. The Prostate Cancer UK free risk checker tool can help you understand your personal risk level.
In many Afro-Caribbean communities, prostate health is surrounded by silence. The digital rectal examination (DRE) — though increasingly replaced by MRI-first pathways — has historically been a barrier to men seeking help. Cultural taboos around male vulnerability, combined with experiences of healthcare inequality, create additional barriers.
Organisations working to change this include:
Based on guidance from the World Cancer Research Fund, Prostate Cancer Foundation, and NHS, here are evidence-informed daily and weekly practices:
Select the questions relevant to you. Print or screenshot this list for your next appointment. Being prepared helps you get the most from your consultation. The Prostate Cancer UK talking to your doctor guide also provides useful preparation tips.
Reading this page means you care about your health. Share it with someone who needs it.